A new four-month treatment course for drug-sensitive tuberculosis (the most common form of TB by far) is as safe and effective as the current six-month treatment course that has been in use since the 1980s, according to findings from a large new study. Amy Green reports.
A World Health Organization report published last week showed more people are falling ill with tuberculosis in South Africa than previously thought – but also that the country’s treatment success rate for dangerous drug-resistant forms of the disease have improved. Amy Green asks what’s behind these numbers.
In recent months, the world has seen unprecedented investment in new vaccines. Yet, while a COVID-19 vaccine proven to be safe and effective may be less than a year away, a new tuberculosis vaccine might only be ready to be rolled out in a decade, despite a massive head start over COVID-19. Amy Green takes a closer look at the race for a new vaccine for the world’s top infectious disease killer.
Around 20% more people are falling ill with tuberculosis (TB) in South Africa, than previously thought. This emerged from new estimates contained in the 2020 WHO World TB Report launched today.
People with COVID-19 and people with tuberculosis (TB) can experience similar symptoms such as coughing and breathing difficulties as both diseases affect the lungs. Exactly how these diseases affect the lungs, however, differs. Tiyese Jeranji spoke to a leading South African pulmonologist to learn more.
Some tuberculosis patients in South Africa are still required to take their pills in front of a healthcare worker or family member. Is this a justified means of ensuring people take their medicine, or is it an invasion of personal autonomy? Elri Voigt asked local TB experts.
Even though it has been ready for months, findings of a critically important tuberculosis survey have not been made public. Every day that passes, the more outdated the findings become, and accordingly the less useful.
A leading TB doctor says that “it is no exaggeration to say there is a TB crisis in the country”, and that “the impact of this crisis could be even more devastating than COVID-19”. Kathryn Cleary explores the COVID-19 pandemic’s impact on South Africa’s TB response and the way forward.
It seems HIV and TB are falling by the wayside in the drive to stop the spread of COVID-19. Where we can we must minimise the harm to the HIV and TB response, and we need to see the opportunity to address all three diseases together, writes Erica Penfold.
Tuberculosis (TB) testing rates are down by almost half and dramatically fewer TB patients are starting treatment. Kathryn Cleary takes an in-depth look at the impact of COVID-19 and the lockdown on TB services in South Africa.
The use of the BCG vaccine for an unproven indication is irresponsible and may deplete BCG stocks for young children, for whom it has been proven to be a lifesaving preventive tool against TB, argue a group of leading experts.